<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-75781</identifier>
<setSpec>1699-8855</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Malignant mixed müllerian tumour of the uterine cervix. Report of a case and review of the literature</dc:title>
<dc:description xml:lang="en">Introduction: Malignant mixed müllerian tumors(MMMTs) or malignant mixed mesodermal tumours of thecervix are exceptionally rare, probably accounting for&lt;3% of all uterine MMMTs; fewer than 50 cases havebeen reported to date. They tend to be highly aggressiveand generally have a poor prognosis. Methods:We presentthe clinical and histological features of a case of MMMTof the cervix and review the literature. Representative sectionswere stained with hematoxylin-eosin and immunohistochemistrywas performed using the streptavidin-biotinperoxidase method for cytokeratin, carcinoembryonicantigen, CD10, calretinin, vimentin, desmin and myoglobin.Results: the tumour was biphasic, composed of anadmixture of neoplastic epithelial and homologous andheterologous mesenchymal components. The epithelialcomponent was positive for cytokeratin and carcinoembryonicantigen and negative for CD10, calretinin andvimentin. The heterologous component was positive fordesmin and myoglobin. Conclusions: we report a case ofmalignant mixed müllerian tumour arising in the uterinecervix and review the literature(AU)</dc:description>
<dc:creator>Solís García, Eduardo</dc:creator>
<dc:creator>Segura Sánchez, Juan</dc:creator>
<dc:creator>González Serrano, Teresa</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">Introducción: Los tumores müllerianos mixtosmalignos (TMMM) de cervix o tumores mesodérmicosmixtos malignos son neoplasias infrecuentes con pocomás de 50 casos descritos en la literatura y probablementeconstituyen &lt;3% de todos los TMMM uterinos. Sonmuy agresivos y generalmente se asocian a mal pronóstico.Método: Hemos revisado las características histológicas,clínicas y la literatura médica. Secciones representativashan sido teñidas con hematoxilina-eosina. El estudioinmunohistoquímico se realizó con el método estreptavidina-biotina-peroxidasa para citoqueratina, antígeno carcinoembrionario,CD10, calretinina, vimentina, desminay mioglobina. Resultado: El tumor es bifásico compuestode una mezcla de componente epitelial y mesenquimalhomólogo y heterólogo. Las tinciones inmunohistoquímicasmostraron positividad para citoqueratina y antígenocarcinoembrionario y negatividad para CD10, calretininay vimentina en el componente epitelial. El componenteheterólogo mostró positividad para desmina y mioglobina.Conclusión: Aportamos un nuevo caso de tumormülleriano mixto maligno originado en cérvix uterino yrevisamos la literatura(AU)</dc:description>
<dc:source>Rev. esp. patol;42(4): 300-303, oct.-dic.2009. ilus</dc:source>
<dc:identifier>ibc-75781</dc:identifier>
<dc:title xml:lang="es">Tumor mülleriano mixto maligno del cérvix uterino. A propósito de un caso y revisión de la literatura</dc:title>
<dc:subject>^d29611</dc:subject>
<dc:subject>^d238^s22012</dc:subject>
<dc:subject>^d238^s22016</dc:subject>
<dc:subject>^d22921^s22045</dc:subject>
<dc:subject>^d31300^s22016</dc:subject>
<dc:subject>^d21012</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d3965</dc:subject>
<dc:subject>^d2623^s22053</dc:subject>
<dc:subject>^d21030</dc:subject>
<dc:subject>^d2617^s22012</dc:subject>
<dc:subject>^d7225^s22045</dc:subject>
<dc:subject>^d2617^s22016</dc:subject>
<dc:subject>^d2623^s22012</dc:subject>
<dc:subject>^d9062</dc:subject>
<dc:subject>^d31300^s22012</dc:subject>
<dc:subject>^d31300^s22053</dc:subject>
<dc:subject>^d31300^s29166</dc:subject>
<dc:type>article</dc:type>
<dc:date>200912</dc:date>
</metadata>
</record>
</ibecs-document>
